Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

Switching From Tirzepatide to semaglutide for weight loss? This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: You can switch from tirzepatide to ...

Over the last few years, semaglutide has truly taken over. It's likely that you have more than one family member, friend, or colleague who's taken it and raved about the metabolic results they've seen ...

If you’re considering a semaglutide medication like Ozempic or Wegovy for weight loss, you may be a bit worried about the weekly injections. Both medications come in a pre-filled pen so you can inject ...

Weight Loss Medications Available Online If you’re eligible for weight loss medication, there are a fair number of options. Your provider will go over your unique … ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide ...

There are three main types of injectable weight loss drugs approved by the Food and Drug Administration (FDA): semaglutide, liraglutide and tirzepatide. These are administered either daily or weekly ...

Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...

VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the ...